About Caidya

Caidya works as a global, multi-therapeutic clinical research organization (CRO) focused on advancing healthcare innovation and accelerating the development of new therapies. The company offers comprehensive clinical trial services, including regulatory strategy and submissions, clinical operations, biometrics, and quality management, as well as post-approval surveillance. Caidya serves a broad range of sectors within the healthcare industry, leveraging its in-depth therapeutic and operational expertise to conduct studies efficiently and with high quality standards. Caidya was formerly known as dMed Biopharmaceutical. It was founded in 2021 and is based in Raleigh, North Carolina.